Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.032 EUR | -5.84% | +10.15% | -42.73% |
14/03 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
11/03 | Abionyx: reduced net loss in 2023 | CF |
Quotes 5-day view
Delayed Quote Börse Stuttgart14/05/2024 | 15/05/2024 | 16/05/2024 | 17/05/2024 | |
---|---|---|---|---|
Last | 1.116 € | 1.11 € | 1.096 € | 1.032 € |
Change | +13.76% | -0.54% | -1.26% | -5.84% |
Performance
1 day | -5.84% | ||
Current month | -2.64% | ||
3 months | -0.77% | ||
6 months | -0.77% | ||
Current year | -42.73% | ||
1 year | -0.77% | ||
3 years | -0.77% | ||
5 years | +156.40% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-5.84% | +10.15% | -42.73% | -0.77% | 40.89M | ||
+1.04% | +6.26% | +9.42% | +28.99% | 114B | ||
+1.48% | +1.48% | +11.84% | +32.33% | 104B | ||
-2.55% | -1.58% | -14.15% | -14.20% | 22.41B | ||
-1.45% | -2.58% | -1.05% | -8.28% | 22.28B | ||
+0.74% | +1.90% | -5.29% | -28.18% | 19.07B | ||
-1.49% | -1.04% | -38.29% | -34.78% | 18B | ||
+1.06% | +2.50% | -4.16% | -27.65% | 17.89B | ||
+0.27% | +1.88% | +7.99% | +50.84% | 14.28B | ||
-1.02% | -0.70% | +36.24% | -11.91% | 12.55B | ||
-2.61% | -0.79% | -24.95% | -37.92% | 8.45B | ||
-1.17% | +13.73% | +18.74% | +54.55% | 8.21B | ||
-3.43% | -3.57% | -52.50% | -69.89% | 7.76B | ||
-0.59% | -0.47% | -0.71% | +33.86% | 7.72B | ||
-2.98% | -16.46% | +260.02% | +171.86% | 7.62B | ||
-1.37% | -9.02% | -3.83% | +29.73% | 7.04B | ||
Average | -1.24% | +0.14% | +9.79% | +10.54% | ||
Weighted average by Cap. | +0.22% | +1.50% | +8.06% | +16.49% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -41.18% | ||
2023 | -6.34% | ||
2022 | -17.78% | ||
2021 | +149.47% | ||
2020 | +213.19% | ||
2019 | -40.22% | ||
2018 | -72.95% | ||
2017 | -36.14% |
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- Quotes ABIONYX Pharma